ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 182986 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 182986; 2) Community: the network communities that were significantly associated with the response to NSC 182986; 3) Molecule: the relationships between components within communities and NSC 182986; 4) MDR: the compounds that were significantly associated with the NSC 182986.

NSC Compound Enrichment Correlation
NSC 670765 Null 0.0283958753782624 -0.023596833
NSC 677776 Null 0.0283958753782624 0.053282259
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0283958753782624 0.10226701
NSC 679800 Null 0.0283958753782624 0.19194968
NSC 681636 Camptothecin Derivative 0.0283958753782624 0.71806153
NSC 681645 Camptothecin Derivative 0.0283958753782624 0.72435665
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0283958753782624 0.46724793
NSC 696662 (6R,6S)-2,4-Diamino-6-(2,5-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.0283958753782624 0.32139235
NSC 700657 Trapoxin B 0.0283958753782624 0.14029673
NSC 701984 4H,9H-Naphtho[2,3-b]furan-2-carboxaldehyde, 4,9-dioxo- 0.0283958753782624 0.19079595
Total:71  Current:44    [First] [Prev] [Next] [Last]